Glaukos Corporation
$133.42
$2.43(-1.79%)
Glaukos Corporation
GKOS
$133.42
$2.43(-1.79%)
Glaukos Corporation
GKOS
NYSE
$133.42
$2.43(-1.79%)
Chart
Upcoming Earnings
Next report date
Jul 29, 2026
Report period
Q3 2026
EPS Estimate
$-0.21
Revenue Estimate
$151.08M
Key stats
52-Week Range$133.42
$73.16
$146.75
Market capitalization
$7.81BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-42.97Basic EPS (TTM)
$-3.26Net income (TTM)
$-187.69MRevenue (TTM)
$507.44MAvg. volume
761.77KBeta (1Y)
0.78Employees
995Market capitalization
$7.81BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-42.97Basic EPS (TTM)
$-3.26Net income (TTM)
$-187.69MRevenue (TTM)
$507.44MAvg. volume
761.77KBeta (1Y)
0.78Employees
995Screener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Glaukos Corporation
Sector
Healthcare
Industry
Medical - Devices
CEO
Thomas William Burns
Website
www.glaukos.comHeadquarters
229 Avenida Fabricante, Aliso Viejo, CA, 92672
IPO Date
2015-06-25
Identifiers
ISIN
US3773221029Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies...
Related Stocks
$74.93
1D:
-1.9%
1Y:
436.0%
US04280A1007Healthcare
Mkt Cap
$10.49B
P/E Ratio TTM
51.8
Revenue TTM
$1.09B
Beta
1.27
Earnings TTM
$202.27M
Dividend Yield TTM
0.00%
$115.07
1D:
0.0%
1Y:
78.0%
US03940C1009Healthcare
Mkt Cap
$6.73B
P/E Ratio TTM
-28.3
Revenue TTM
$22.29M
Beta
0.25
Earnings TTM
$-228.93M
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate